NCT01784562No Longer Available不适用
An Open-label Phase IIIb Study of Riociguat in Patients With In-operable CTEPH, or Recurrent or Persisting PH After Surgical Treatment Who Are Not Satisfactorily Treated and Cannot Participate in Any Other CTEPH Trial
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 发起方
- Bayer
研究概览
简要总结
The aim of the study is to assess safety, tolerability and clinical effects of different doses of riociguat in patients with inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and who are not satisfactorily treated and cannot participate in any other CTEPH trial. In the US the study runs as an Expanded Access program under 21 CFR 312.320.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female patients with CTEPH either inoperable or with persistent or recurrent PH after surgery
排除标准
- •All types of pulmonary hypertension other than Dana Point Classification Group 4
- •Operable patients listed for PEA (Pulmonary Endarterectomy)
研究者
相似试验
终止
2 期
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic DysfunctionHypertension, PulmonaryVentricular Dysfunction, LeftNCT01065454Bayer202
已完成
3 期
A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)Atopic DermatitisNCT05633355Amgen187
终止
2 期
Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)Idiopathic Interstitial Pneumonias / Hypertension,PulmonaryNCT02138825Bayer147
已完成
3 期
A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TBPulmonary TuberculosisNCT02333799Global Alliance for TB Drug Development109
已完成
不适用
Effect of Riocigaut on Cerebral Vasodilation and Headache Induction in Healthy VolunteersHeadacheNCT05582811Danish Headache Center15